Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2022-08-02 Sale |
2022-08-04 6:24 pm |
Nabriva Therapeutics plc | NBRV | BURGESS DANIEL D Director |
11,341 | $0.1901 | $2,156 | 10,384 (Direct) |
View |
2021-08-02 Sale |
2021-08-04 9:07 pm |
Nabriva Therapeutics plc | NBRV | BURGESS DANIEL D Director |
1,125 | $1.2 | $1,350 | 21,725 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2024-12-17 Option Award |
2024-12-19 6:20 pm |
N/A 2034-12-16 |
Cidara Therapeutics Inc. | CDTX | BURGESS DANIEL D Director |
20,500 | $0 | 20,500 (Direct) |
View |
2024-07-18 Option Award |
2024-07-19 4:56 pm |
N/A 2034-07-17 |
Cidara Therapeutics Inc. | CDTX | BURGESS DANIEL D Director |
2,125 | $0 | 2,125 (Direct) |
View |
2024-05-23 Option Award |
2024-05-24 4:17 pm |
2024-05-23 2034-05-23 |
Arbutus Biopharma Corp | ABUS | BURGESS DANIEL D Director |
67,000 | $0 | 67,000 (Direct) |
View |
2023-06-22 Option Award |
2023-06-23 5:19 pm |
N/A 2033-06-21 |
Cidara Therapeutics Inc. | CDTX | BURGESS DANIEL D Director |
42,500 | $0 | 42,500 (Direct) |
View |
2023-05-24 Option Award |
2023-05-26 4:22 pm |
2023-05-24 2033-05-24 |
Arbutus Biopharma Corp | ABUS | BURGESS DANIEL D Director |
55,000 | $0 | 55,000 (Direct) |
View |
2022-06-22 Option Award |
2022-06-24 5:33 pm |
N/A 2032-06-21 |
Cidara Therapeutics Inc. | CDTX | BURGESS DANIEL D Director |
28,000 | $0 | 28,000 (Direct) |
View |
2022-05-25 Option Award |
2022-05-26 4:17 pm |
2022-05-25 2032-05-25 |
Arbutus Biopharma Corp | ABUS | BURGESS DANIEL D Director |
41,000 | $0 | 41,000 (Direct) |
View |
2021-07-28 Option Award |
2021-07-30 8:23 pm |
N/A 2031-07-27 |
Nabriva Therapeutics plc | NBRV | BURGESS DANIEL D Director |
52,500 | $0 | 57,850 (Direct) |
View |
2021-06-23 Option Award |
2021-06-24 5:55 pm |
N/A 2031-06-22 |
Cidara Therapeutics Inc. | CDTX | BURGESS DANIEL D Director |
17,500 | $0 | 17,500 (Direct) |
View |
2021-06-03 Option Award |
2021-06-07 4:25 pm |
2021-06-03 2031-06-03 |
Arbutus Biopharma Corp | ABUS | BURGESS DANIEL D Director |
22,000 | $0 | 22,000 (Direct) |
View |
2020-07-29 Option Award |
2020-07-31 4:54 pm |
N/A 2030-07-28 |
Nabriva Therapeutics plc | NBRV | BURGESS DANIEL D Director |
52,500 | $0 | 88,500 (Direct) |
View |
2020-06-25 Option Award |
2020-06-25 6:48 pm |
N/A 2030-06-24 |
Cidara Therapeutics Inc. | CDTX | BURGESS DANIEL D Director |
17,500 | $0 | 17,500 (Direct) |
View |
2020-05-28 Option Award |
2020-06-01 4:56 pm |
2020-05-28 2030-05-28 |
Arbutus Biopharma Corp | ABUS | BURGESS DANIEL D Director |
22,000 | $0 | 22,000 (Direct) |
View |